机构:
European Med Evaluat Agcy, Unit Evaluat Med Prod Human Use, London E14 4HB, EnglandEuropean Med Evaluat Agcy, Unit Evaluat Med Prod Human Use, London E14 4HB, England
Bass, R
[1
]
Purves, J
论文数: 0引用数: 0
h-index: 0
机构:
European Med Evaluat Agcy, Unit Evaluat Med Prod Human Use, London E14 4HB, EnglandEuropean Med Evaluat Agcy, Unit Evaluat Med Prod Human Use, London E14 4HB, England
Purves, J
[1
]
Amati, MP
论文数: 0引用数: 0
h-index: 0
机构:
European Med Evaluat Agcy, Unit Evaluat Med Prod Human Use, London E14 4HB, EnglandEuropean Med Evaluat Agcy, Unit Evaluat Med Prod Human Use, London E14 4HB, England
Amati, MP
[1
]
机构:
[1] European Med Evaluat Agcy, Unit Evaluat Med Prod Human Use, London E14 4HB, England
来源:
PHARMACOLOGY & TOXICOLOGY
|
2000年
/
86卷
关键词:
D O I:
10.1034/j.1600-0773.2000.d01-8.x
中图分类号:
R9 [药学];
学科分类号:
1007 ;
摘要:
The safety of biotechnological products used for medicinal products is addressed by EU council directives. The general principles and the regulatory framework for the handling of new drug applications within this areas are described both with respect to benefit/risk evaluation, quality assessment, preclinical safety and efficacy testing.